[PLX] YoY Annual Result on 31-Dec-2009 [#FY]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
25-Feb-2010
Financial Year
2009
Quarter
31-Dec-2009 [#FY]
Profit Trend
YoY- -40.27%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Annual Result
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
Revenue 34,424 8,386 6,642 388 0 0 150 147.23%
PBT -11,618 2 28,998 31,440 22,414 -2,080 5,746 -
Tax 0 43,306 48,792 62,880 44,828 -2,086 11,154 -
NP -11,618 -36,529 -28,998 -31,440 -22,414 -22,481 -9,390 3.60%
Tax Rate - -2,165,300.00% -168.26% -200.00% -200.00% - -194.12% -
Total Cost 46,042 44,915 35,640 31,828 22,414 22,481 9,540 29.96%
Ratio Analysis
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
NP Margin -33.75 -435.60 -436.59 -8,103.09 0.00 0.00 -6,260.00 -58.09%
Per Share
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
EPS -0.13 -0.43 -0.36 -0.41 -0.30 -3.35 -0.32 -13.92%
EPS Diluted -0.13 -0.43 -0.36 -0.41 -0.30 -3.35 -0.32 -13.92%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.